Impact of metallothionein gene polymorphisms on the risk of lung cancer in a Japanese population

Molecular Carcinogenesis

Volumn 54, Issue S1, 2015, Pages E122-E128

  Nakane, Hideo ^a,b   Hirano, Minoru ^a   Ito, Hidemi ^b   Hosono, Satoyo ^b   Oze, Isao ^b   Matsuda, Fumihiko ^c   Tanaka, Hideo ^b   Matsuo, Keitaro ^d  

^a Rd Management Section   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Case control study; Gene environment interaction; Single nucleotide polymorphism

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DRINKING; FEMALE; FOOD INTAKE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; JAPANESE (PEOPLE); LIFESTYLE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METALLOTHIONEIN GENE; PRIORITY JOURNAL; SMOKING; VEGETABLE; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; JAPAN; LUNG TUMOR; MIDDLE AGED;

METALLOTHIONEIN;

ADULT; AGED; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; METALLOTHIONEIN; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84931082927     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22198     Document Type: Article

References (25)

1. Margoshes M, Vallee BL. A cadmium protein from equine kidney cortex. J Am Chem Soc 1957;79:4813-4814.
2. Ruttkay-Nedecky B, Nejdl L, Gumulec J, et al. The role of metallothionein in oxidative stress. Int J Mol Sci 2013;14: 6044-6066.
3. Takaishi M, Shimada A, Suzuki JS, Sato M, Nagase H. Involvement of metallothionein (MT) as a biological protective factor against carcinogenesis induced by benzo[a]pyrene (B[a] P). J Toxicol Sci 2010;35:225-230.
4. Miles AT, Hawksworth GM, Beattie JH, Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 2000; 35:35-70.
5. Werynska B, Pula B, Muszczynska-Bernhard B, et al. Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients. Exp Mol Pathol 2013;94: 301-308.
6. Werynska B, Pula B, Muszczynska-Bernhard B, et al. Expression of metallothionein-III in patients with non-small cell lung cancer. Anticancer Res 2013;33:965-974.
7. Tajima K, Hirose K, Inoue M, Takezaki T, Hamajima H, Kuroishi T. A model of practical cancer prevention for out-patients visiting a hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Asian Pacific J Cancer Prev 2000;1:35-47.
8. Hamajima N, Matsuo K, Saito T, et al. Gene-environment interactions and polymorphism studies of cancer risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pacific J Cancer Prev 2001;2:99-107.
9. West AK, Stallings R, Hildebrand CE, Chiu R, Karin M, Richards RI. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 1990;8:513-518.
10. Tokudome S, Ikeda M, Tokudome Y, Imaeda N, Kitagawa I, Fujiwara N. Development of data-based semi-quantitative food frequency questionnaire for dietary studies in middleaged Japanese. Jpn J Clin Oncol 1998;28:679-687.
11. Tokudome S, Goto C, Imaeda N, Tokudome Y, Ikeda M, Maki S. Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese. Asian Pacific J Cancer Prev 2004;5:40-43.
12. Sato M, Bremner I. Oxygen free radicals and metallothionein. Free Radic Bio Med 1993;14:325-337.
13. Chiaverini N, De Ley M. Protective effect of metallothionein on oxidative stress-induced DNA damage. Free Radic Res 2010; 44:605-613.
14. Waalkes MP, Liu J, Goyer RA, Diwan BA. Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: role of inclusion body formation. Cancer Res 2004;64:7766-7772.
15. Han YC, Zheng ZL, Zuo ZH, et al. Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1. J Patho 2013;230:184-193.
16. Theocharis S, Karkantaris C, Philipides T, et al. Expression of metallothionein in lung carcinoma: correlation with histological type and grade. Histopathology 2002;40:143-151.
17. Shimoda R, Achanzar WE, Qu W, et al. Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci 2003; 73:294-300.
18. Zavras AI, Yoon AJ, Chen MK, Lin CW, Yang SF. Metallothionein- 1 genotypes in the risk of oral squamous cell carcinoma. Ann Surg Oncol 2011;18:1478-1483.
19. Wong RH, Huang CH, Yeh CB, Lee HS, Chien MH, Yang SF. Effects of metallothionein-1 genetic polymorphism and cigarette smoking on the development of hepatocellular carcinoma. Ann Surg Oncol 2013;20:2088-2095.
20. Seibold P, Hein R, Schmezer P, et al. Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk. Int J Cancer 2011;129:1467-1476.
21. Krzeslak A, Forma E, Józwiak P, et al. Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer. Clin Exp Med 2014;14:107-113.
22. Forma E, Krzeslak A, Wikosz J, et al. Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population. Cancer Genet 2012;205:432-435.
23. Gilks CB, Price K, Wright JL, Churg A. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathol 1998;152:269-278.
24. Koomägi R, Stammler G, Manegold C, Mattern J, Volm M. Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer. Cancer Lett 1996;110:129-136.
25. Inoue M, Tajima K, Hirose K, et al. Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age, and season. J Clin Epidemiol 1997;50:69-77.